https://news.medxy.ai/zh/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia-4/Medxy AIzh2026-07-06T09:55:48-07:00抑制 EGR1/DUSP2 轴增强 MUC1-Tn CAR T 细胞治疗：linperlisib 对 T-ALL 的协同抗白血病作用 https://news.medxy.ai/ja/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia-3/Medxy AIja2026-07-06T09:55:29-07:00EGR1/DUSP2軸抑制によるリンペルリシブの増強効果：T細胞急性リンパ芽球性白血病に対するMUC1-Tn CAR T細胞療法 https://news.medxy.ai/vi/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia-2/Medxy AIvi2026-07-06T09:55:08-07:00Linperlisib tăng cường liệu pháp CAR-T MUC1-Tn bằng ức chế trục EGR1/DUSP2 để chống lại bệnh bạch cầu cấp dòng tế bào T https://news.medxy.ai/linperlisib-potentiates-muc1-tn-car-t-cell-therapy-by-suppressing-the-egr1-dusp2-axis-to-combat-t-cell-acute-lymphoblastic-leukemia/Medxy AIen2026-07-06T09:53:57-07:00Linperlisib Potentiates MUC1-Tn CAR T Cell Therapy by Suppressing the EGR1/DUSP2 Axis to Combat T-Cell Acute Lymphoblastic Leukemia https://news.medxy.ai/ja/engineering-single-chain-variable-fragments-to-identify-pathogenic-antibodies-in-heparin-induced-thrombocytopenia-3/Medxy AIja2026-07-06T09:43:54-07:00ヘパリン起因性血小板減少症における病原性抗体を見極める単鎖可変断片工学 https://news.medxy.ai/vi/engineering-single-chain-variable-fragments-to-identify-pathogenic-antibodies-in-heparin-induced-thrombocytopenia-2/Medxy AIvi2026-07-06T09:43:36-07:00Thiết kế scFv để nhận diện kháng thể gây bệnh trong giảm tiểu cầu do heparin https://news.medxy.ai/engineering-single-chain-variable-fragments-to-identify-pathogenic-antibodies-in-heparin-induced-thrombocytopenia/Medxy AIen2026-07-06T09:42:48-07:00Engineering Single-Chain Variable Fragments to Identify Pathogenic Antibodies in Heparin-Induced Thrombocytopenia https://news.medxy.ai/zh/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients-2/Medxy AIzh2026-07-05T21:53:44-07:00短期高海拔暴露对肺血管疾病患者右心负荷与氧输送的影响 https://news.medxy.ai/ja/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients-3/Medxy AIja2026-07-05T21:53:28-07:00短期高地曝露が肺血管疾患患者の右心室負荷と酸素運搬に及ぼす影響 https://news.medxy.ai/vi/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients-4/Medxy AIvi2026-07-05T21:53:10-07:00Tác động của phơi nhiễm ngắn hạn ở độ cao lớn lên hậu gánh thất phải và cung cấp oxy ở bệnh nhân bệnh mạch máu phổi https://news.medxy.ai/impact-of-short-term-high-altitude-exposure-on-right-ventricular-load-and-oxygen-delivery-in-pulmonary-vascular-disease-patients/Medxy AIen2026-07-05T21:52:09-07:00Impact of Short-Term High-Altitude Exposure on Right Ventricular Load and Oxygen Delivery in Pulmonary Vascular Disease Patients https://news.medxy.ai/zh/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes-2/Medxy AIzh2026-07-05T20:02:18-07:00脓毒症低血压早期补液：限制性与宽松性策略对长期患者结局的影响比较 https://news.medxy.ai/ja/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes-3/Medxy AIja2026-07-05T20:02:02-07:00敗血症性低血圧における早期制限的輸液と自由輸液の比較：患者中心アウトカムへの長期影響 https://news.medxy.ai/vi/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes-4/Medxy AIvi2026-07-05T20:01:44-07:00So sánh chiến lược hồi sức dịch sớm hạn chế và tự do trong hạ huyết áp do nhiễm khuẩn huyết: tác động dài hạn lên các kết cục lấy người bệnh làm trung tâm https://news.medxy.ai/comparing-early-restrictive-and-liberal-fluid-strategies-in-sepsis-induced-hypotension-long-term-effects-on-patient-centered-outcomes/Medxy AIen2026-07-05T20:00:49-07:00Comparing Early Restrictive and Liberal Fluid Strategies in Sepsis-Induced Hypotension: Long-Term Effects on Patient-Centered Outcomes https://news.medxy.ai/vi/corneal-nerve-alterations-and-sensory-deficits-in-unilateral-noninfectious-anterior-uveitis-a-cross-sectional-study-2/Medxy AIvi2026-07-05T17:52:40-07:00Thay đổi thần kinh giác mạc và suy giảm cảm giác trong viêm màng bồ đào trước không nhiễm trùng một bên: nghiên cứu cắt ngang https://news.medxy.ai/corneal-nerve-alterations-and-sensory-deficits-in-unilateral-noninfectious-anterior-uveitis-a-cross-sectional-study/Medxy AIen2026-07-05T17:52:02-07:00Corneal Nerve Alterations and Sensory Deficits in Unilateral Noninfectious Anterior Uveitis: A Cross-Sectional Study https://news.medxy.ai/zh/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection-4/Medxy AIzh2026-07-05T17:49:11-07:00近视眼青光眼诊断新进展：基于OCT的预设规则用于视神经病变检出验证 https://news.medxy.ai/ja/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection-3/Medxy AIja2026-07-05T17:48:57-07:00近視における緑内障診断を高精度化：OCTで検証した視神経障害検出ルール https://news.medxy.ai/vi/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection-2/Medxy AIvi2026-07-05T17:48:42-07:00Nâng cao chẩn đoán glaucoma ở bệnh nhân cận thị: xác thực các quy tắc OCT được xác định trước để phát hiện bệnh lý thần kinh thị giác https://news.medxy.ai/enhancing-glaucoma-diagnosis-in-myopia-validating-oct-based-prespecified-rules-for-optic-neuropathy-detection/Medxy AIen2026-07-05T17:48:05-07:00Enhancing Glaucoma Diagnosis in Myopia: Validating OCT-Based Prespecified Rules for Optic Neuropathy Detection https://news.medxy.ai/disparities-in-access-to-intravitreal-anti-vegf-therapies-among-medicare-advantage-versus-fee-for-service-beneficiaries/Medxy AIen2026-07-05T17:46:50-07:00Disparities in Access to Intravitreal Anti-VEGF Therapies Among Medicare Advantage Versus Fee-for-Service Beneficiaries https://news.medxy.ai/zh/%e8%a1%80%e9%94%b0%e5%8d%87%e9%ab%98%e6%88%96%e5%a2%9e%e5%8a%a0%e5%a4%b4%e9%a2%88%e9%83%a8%e9%b3%9e%e7%8a%b6%e7%bb%86%e8%83%9e%e7%99%8c%e9%a3%8e%e9%99%a9%ef%bc%9a%e5%ad%9f%e5%be%b7%e5%b0%94%e9%9a%8f/Medxy AIzh2026-07-05T17:42:12-07:00血锰升高或增加头颈部鳞状细胞癌风险：孟德尔随机化研究新发现 https://news.medxy.ai/ja/elevated-blood-manganese-linked-to-increased-risk-of-head-and-neck-squamous-cell-carcinomas-insights-from-mendelian-randomization-2/Medxy AIja2026-07-05T17:41:57-07:00血中マンガン高値は頭頸部扁平上皮癌リスク上昇と関連 ― Mendelian randomization研究から見えた新知見 https://news.medxy.ai/vi/elevated-blood-manganese-linked-to-increased-risk-of-head-and-neck-squamous-cell-carcinomas-insights-from-mendelian-randomization-3/Medxy AIvi2026-07-05T17:41:40-07:00Mangan trong máu tăng cao có liên quan đến nguy cơ ung thư biểu mô tế bào vảy đầu và cổ tăng lên: Góc nhìn từ ngẫu nhiên Mendel https://news.medxy.ai/elevated-blood-manganese-linked-to-increased-risk-of-head-and-neck-squamous-cell-carcinomas-insights-from-mendelian-randomization/Medxy AIen2026-07-05T17:41:03-07:00Elevated Blood Manganese Linked to Increased Risk of Head and Neck Squamous Cell Carcinomas: Insights from Mendelian Randomization https://news.medxy.ai/zh/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy-4/Medxy AIzh2026-07-05T17:38:50-07:00改良衰弱指数在全甲状腺切除术短期并发症中的预测价值 https://news.medxy.ai/ja/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy-3/Medxy AIja2026-07-05T17:38:35-07:00全甲状腺摘出術後早期合併症を予測する修正フレイル指数の有用性 https://news.medxy.ai/vi/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy-2/Medxy AIvi2026-07-05T17:38:19-07:00Vai trò dự báo của Chỉ số suy yếu sửa đổi trong biến chứng ngắn hạn sau cắt toàn bộ tuyến giáp https://news.medxy.ai/predictive-role-of-the-modified-frailty-index-in-short-term-complications-after-total-thyroidectomy/Medxy AIen2026-07-05T17:37:43-07:00Predictive Role of the Modified Frailty Index in Short-Term Complications After Total Thyroidectomy https://news.medxy.ai/zh/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation-4/Medxy AIzh2026-07-05T16:49:55-07:00复杂性肛瘘的瘘管切开术联合一期括约肌成形术：在治愈与控便保护之间取得平衡 https://news.medxy.ai/ja/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation-3/Medxy AIja2026-07-05T16:49:42-07:00複雑痔瘻に対する瘻管切開術＋原発性括約筋形成術：治癒と失禁温存の両立を目指して https://news.medxy.ai/vi/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation-2/Medxy AIvi2026-07-05T16:49:27-07:00Cắt đường rò kết hợp tạo hình cơ thắt nguyên phát cho rò hậu môn phức tạp: Cân bằng giữa chữa khỏi và bảo tồn chức năng tự chủ https://news.medxy.ai/fistulotomy-with-primary-sphincteroplasty-for-complex-anal-fistulas-balancing-cure-with-continence-preservation/Medxy AIen2026-07-05T16:48:50-07:00Fistulotomy with Primary Sphincteroplasty for Complex Anal Fistulas: Balancing Cure with Continence Preservation https://news.medxy.ai/zh/hr%e9%98%b3%e6%80%a7dcis%e4%bf%9d%e4%b9%b3%e5%88%87%e7%bc%98%e9%9c%80%e8%a6%81%e5%a4%9a%e5%ae%bd%ef%bc%9f-nrg-oncology-nsabp-b-35%e8%af%95%e9%aa%8c%e5%b8%a6%e6%9d%a5%e7%9a%84%e6%96%b0/Medxy AIzh2026-07-05T16:41:37-07:00HR阳性DCIS保乳切缘需要多宽？——NRG Oncology/NSABP B-35试验带来的新启示 https://news.medxy.ai/ja/reevaluating-lumpectomy-margin-thresholds-in-hr-positive-dcis-insights-from-the-nrg-oncology-nsabp-b-35-trial-3/Medxy AIja2026-07-05T16:41:23-07:00HR陽性DCISにおける乳房温存切除断端の閾値を再考する：NRG Oncology/NSABP B-35試験からの知見 https://news.medxy.ai/vi/reevaluating-lumpectomy-margin-thresholds-in-hr-positive-dcis-insights-from-the-nrg-oncology-nsabp-b-35-trial-2/Medxy AIvi2026-07-05T16:41:05-07:00Xem xét lại ngưỡng bờ cắt sau lumpectomy trong DCIS thụ thể hormone dương tính: Góc nhìn từ thử nghiệm NRG Oncology/NSABP B-35 https://news.medxy.ai/reevaluating-lumpectomy-margin-thresholds-in-hr-positive-dcis-insights-from-the-nrg-oncology-nsabp-b-35-trial/Medxy AIen2026-07-05T16:40:32-07:00Reevaluating Lumpectomy Margin Thresholds in HR-Positive DCIS: Insights from the NRG Oncology/NSABP B-35 Trial